Picture of Cullinan Therapeutics logo

CGEM — Cullinan Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Brief: Cullinan Therapeutics Q3 Operating Expenses USD 55.595 Million

Nov 06 (Reuters) - Cullinan Therapeutics Q3 operating income USD -55.595 million vs. IBES estimate USD -63.3 million.

Q3 net income USD -50.61 million

Q3 cash & investments USD 475.5 million

Recent news on Cullinan Therapeutics

See all news